|Former: Atención Farmacéutica|
|Journal edited by Rasgo Editorial since 1983|
Manuela Velázquez Prieto
EDITOR IN CHIEF
Jaime E. Poquet Jornet
Tomás Casasín Edo
Virginia Hernández Corredoira
Ramón Jódar Masanés
Juan Carlos Juárez Giménez
Volume 21 - Issue 1, January-February 2019
THE CASE OF A HYPEROSMOLAR HYPERGLYCEMIC STATE INDUCED BY FUROSEMIDE IN A DIABETIC PATIENT
ALGAHTANI SAEED F, ALQAHTANI SALEH F, ALQAHTANI FAHAD M, QAHL MOHAMMED
Background: A Hyperosmolar Hyperglycaemic state (HHS) is one of the most serious acute metabolic emergencies in diabetic patients. In HHS, severe hyperglycaemia develops gradually over a period of days or weeks without remarkable ketone production; in other words, without ketosis or severe acidosis.
Case presentation: The patient is a 55-year-old male; he weighs 134 kg and his height is 192 cm. His body mass index (BMI) is 36.35 kg/m2. He is unable to work due to back problems and suffering from shortness of breath on exertion (SOBE). His blood glucose level was high (32.3 mmol/L), with an increase in urinary frequency.
He has type 2 diabetes mellitus, hypertension, and chronic kidney disease. HHS developed after using furosemide in modest doses for seven weeks.
Conclusion: Patients’ urine and blood glucose levels should be monitored at regular intervals in diabetic patients receiving furosemide as it may prompt the development of HHS in patients taking modest doses.
FUROSEMIDE - HYPERGLYCAEMIC - HYPEROSMOLAR